Aeon Respire
Budget
€10 — €0
EP Access
0
accredited persons
Staff
2
0.2 FTE
EU Grants
None
Mission & Goals
Development of a novel inhaled therapy to treat respiratory disease.
EU Legislative Interests
European Commission, Unit: Medical Counter-Measures, European Health Emergency Preparedness and Response Authority (HERA)
Communication Activities
Reach-out to Head of Unit, Unit 03/ Medical Counter-Measures (MCM) European Health Emergency Preparedness and Response Authority (HERA) and submission of introductory presentation of Aeon Respire; introductory meeting with stakeholders and experts covering regulatory aspects, biomedical aspects in the field of anti-infectives and antimicrobial resistance; discussion of developmental opportunities in this important MCM area to achieve key objectives;
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
American Thoracic Society (ATS) https://www.thoracic.org
Additional Information
We are a small Biotech Corporation and establishing contacts with the EU decision makers is a minor part of our professional work that we provide on a voluntary basis without significant logistical expenses; Aeon Respire has no funds and financial resources allocated solely for activities and communication with the European Commission / HERA. The total costs for these activities is thus much less than the lowest category of < 10.000 € because costs for offices/travel/infrastructure etc. do not apply for this purpose;
Commissioner Meetings
No recorded meetings with EU commissioners.